SCHEMBL5028322

SCHEMBL5028322

CCc1cnc(N)nc1-c1cccc(F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.49
ADORA2A P29274 4/20 0.49
PTGDR2 Q9Y5Y4 4/20 0.48
ADORA2B P29275 1/20 0.47
TBXA2R P21731 1/20 0.46
PTGDR Q13258 1/20 0.46
DHFR P00374 3/20 0.43
DPP4 P27487 1/20 0.43
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
CHUK O15111 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
TLR8 Q9NR97 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25559628 0.83 PTGDR2 (0.48) ADORA1ADORA2APTGDR2TBXA2RPTGDR
SCHEMBL15156679 0.82 ADORA1 (0.53) ADORA1ADORA2AALDH1A1MAPT
SCHEMBL30268103 0.82 ADORA1 (0.53) ADORA1ADORA2AALDH1A1MAPT
SCHEMBL5454611 0.81 ADORA1 (0.45) ADORA1ADORA2APTGDR2ADORA2BDHFR
SCHEMBL28402866 0.75 DHFR (0.44) ADORA1ADORA2ADHFRMAPTKMT2A
SCHEMBL29808838 0.75 DHFR (0.44) ADORA1ADORA2ADHFRMAPTKMT2A
SCHEMBL5455467 0.75 ADORA1 (0.64) ADORA1ADORA2AADORA2BDHFR
SCHEMBL3820130 0.74 DPP4 (0.46) ADORA1ADORA2APTGDR2ADORA2BTBXA2R
SCHEMBL5447978 0.73 ADORA1 (0.69) ADORA1ADORA2AADORA2BDHFRKMT2A
SCHEMBL19344296 0.72 PTGDR2 (0.46) ADORA2APTGDR2TBXA2RPTGDRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2450358-A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase Elan Pharmaceuticals Inc. (US) 2012-05-09 EP disclosed